Davidson Kempner Capital Management LP Verona Pharma PLC Transaction History
Davidson Kempner Capital Management LP
- $3.2 Billion
- Q3 2025
A detailed history of Davidson Kempner Capital Management LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Davidson Kempner Capital Management LP holds 3,271,623 shares of VRNA stock, worth $350 Million. This represents 10.89% of its overall portfolio holdings.
Number of Shares
3,271,623Holding current value
$350 Million% of portfolio
10.89%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
273Shares Held
72.8MCall Options Held
652KPut Options Held
637K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Glazer Capital, LLC New York, NY3.21MShares$343 Million11.48% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...